Benefits outweigh risks in most scenarios, says FDA review of Pfizer vaccine for children

A review by the Food and Drug Administration (FDA) on Friday indicated that Pfizer-BioNTech’s COVID-19 vaccine provided more benefits to children in most scenarios than possible risk, the latest sign that health authorities could give the green light to a vaccine against children as young as 5 in the coming weeks, The Washington Post reported. … Read more